Abstract

Persistent, low-grade inflammation likely participates in the pathophysiology of both atherosclerosis and kidney disease. Although high-sensitivity C-reactive protein (hsCRP) predicts future cardiovascular risk and chronic kidney disease (CKD), it is unknown whether hsCRP levels predict adverse renal outcomes in patients with cardiovascular disease. Methods: We included All inpatients with clinical and / or biochemical evidence of chronic kidney disease, admitted in the hospital for CKD and cardiovascular disease. Patients who refused to give consent, Critically/terminally ill Patients, Patients with pre-existing cardiac valvular disease, HIV Positive Patients, Patients taking immune-suppressive therapy, Patients on chemo-therapy, Acute kidney injury patient were excluded. After taking institutional ethical clearance and written consent from the patients a cross sectional observational study was conducted on patients admitted in the hospital, who had clinical and / or biochemical evidence of chronic kidney disease. A detailed thorough history was taken, general physical examination, systemic examination and routine and specific lab investigations were done to find out the underlying aetiology, clinical features and outcome of chronic kidney disease. Pro forma I -Informed consent form ANNEXURE G-Master Chart Proforma.

Description